Literature DB >> 2126744

Adult pure red cell aplasia following topical ocular chloramphenicol.

T Fernandez de Sevilla, J Alegre, T Vallespi, V Falco, J M Martinez-Vazquez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126744      PMCID: PMC1042243          DOI: 10.1136/bjo.74.10.640

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

Review 1.  Pure red-cell aplasia.

Authors:  S B Krantz
Journal:  N Engl J Med       Date:  1974-08-15       Impact factor: 91.245

Review 2.  Chloramphenicol-induced bone marrow suppression.

Authors:  A A Yunis
Journal:  Semin Hematol       Date:  1973-07       Impact factor: 3.851

Review 3.  Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.

Authors:  S Chaplin
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1986

Review 4.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

5.  Blood dyscrasias and topically applied chloramphenicol in ophthalmology.

Authors:  F W Besamusca; L A Bastiaensen
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

  5 in total
  4 in total

1.  Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases.

Authors:  R J Mulla; E Barnes; T R Rogers
Journal:  BMJ       Date:  1995-08-12

Review 2.  Ocular chloramphenicol and aplastic anaemia. Is there a link?

Authors:  S A Rayner; R J Buckley
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

3.  Use of chloramphenicol as topical eye medication: time to cry halt?

Authors:  M Doona; J B Walsh
Journal:  BMJ       Date:  1995-05-13

4.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.